These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17460714)

  • 21. Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis.
    Flammer AJ; Sudano I; Hermann F; Gay S; Forster A; Neidhart M; Künzler P; Enseleit F; Périat D; Hermann M; Nussberger J; Luscher TF; Corti R; Noll G; Ruschitzka F
    Circulation; 2008 Apr; 117(17):2262-9. PubMed ID: 18427133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Why were the results of the Heart Outcomes Prevention Evaluation (HOPE) trial so astounding?
    Mancini GB; Stewart DJ
    Can J Cardiol; 2001 May; 17 Suppl A():15A-7A. PubMed ID: 11381289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Future perspectives and implications.
    Sleight P
    Int J Clin Pract Suppl; 2001 Jan; (117):22-3. PubMed ID: 11715355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing.
    Hermida RC; Ayala DE
    Hypertension; 2009 Jul; 54(1):40-6. PubMed ID: 19433778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the angiotensin-converting enzyme inhibitor perindopril on 24-hour blood pressure in patients with lacunar infarction: comparison between dippers and non-dippers.
    Yamamoto Y; Oiwa K; Hayashi M; Ohara T; Muranishi M
    Hypertens Res; 2005 Jul; 28(7):571-8. PubMed ID: 16335885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of adequate blood pressure control in the morning and evening periods in medicated hypertensive patients considered to be controlled in the office.
    Polónia J; Alcântara P; Amado P; Silva JA; Nazaré J; Braz-Nogueira J; Martins L; Carmona J
    Rev Port Cardiol; 2005 Sep; 24(9):1059-72. PubMed ID: 16335281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine pharmacokinetics and blood pressure responses after conversion to once-daily dosing in maintenance liver transplant patients.
    Kovarik JM; Villamil F; Otero A; Levy G; Lynch S; Cillo U; Fischer L; Nashan B; Pollard S; De Carlis L
    Clin Transplant; 2008; 22(1):68-75. PubMed ID: 18217908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lessons learned with ambulatory blood pressure monitoring: a focus on ramipril.
    Burris JF
    Clin Ther; 1993; 15(3):476-85. PubMed ID: 8364940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk.
    Kikuya M; Hansen TW; Thijs L; Björklund-Bodegård K; Kuznetsova T; Ohkubo T; Richart T; Torp-Pedersen C; Lind L; Ibsen H; Imai Y; Staessen JA;
    Circulation; 2007 Apr; 115(16):2145-52. PubMed ID: 17420350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial.
    Lonn E; Shaikholeslami R; Yi Q; Bosch J; Sullivan B; Tanser P; Magi A; Yusuf S
    J Am Coll Cardiol; 2004 Jun; 43(12):2200-6. PubMed ID: 15193680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients.
    Gianni M; Bosch J; Pogue J; Probstfield J; Dagenais G; Yusuf S; Lonn E
    Eur Heart J; 2007 Jun; 28(11):1382-8. PubMed ID: 17395677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis.
    Mancia G; Parati G; Bilo G; Maronati A; Omboni S; Baurecht H; Hennig M; Zanchetti A
    J Hypertens; 2007 May; 25(5):1087-94. PubMed ID: 17414674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
    Andersen K; Weinberger MH; Egan B; Constance CM; Ali MA; Jin J; Keefe DL
    J Hypertens; 2008 Mar; 26(3):589-99. PubMed ID: 18300872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive pulse waveform analysis in clinical trials: similarity of two methods for calculating aortic systolic pressure.
    Adji A; Hirata K; Hoegler S; O'Rourke MF
    Am J Hypertens; 2007 Aug; 20(8):917-22. PubMed ID: 17679043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.